Hematopoietic stem cells: Phase I suspended enrollment

VIAC suspended enrollment in a Phase I trial of CB001 for use in hematopoietic stem cell transplantation to treat cancer. The trial was stopped after 2 cases of grade IV acute graft-versus-host-diseas...